Literature DB >> 874110

Cancer-associated proteins in effusion fluids.

S N Booth, G Lakin, P W Dykes, D Burnett, A R Bradwell.   

Abstract

Two cancer-associated proteins, carcinoembryonic antigen (CEA) and pregnancy-associated alpha2 glycoprotein (PAG), together with 13 normal serum proteins were measured in the serum and effusion fluid of patients with ascites and pleural effusions. The results indicate that CEA measurement in effusion fluid is more effective than serum measurement in distinguishing cancerous from congestive or inflammatory effusions. Comparisons with the results of cytological examination suggest that fluid CEA estimation may prove a useful clinical tool. Serum PAG levels were higher in patients with cancer, but fluid determination offers no advantage in separating the disease groups. Similarly, the estimation of individual normal serum proteins in effusion fluids is unlikely to be of diagnostic value.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874110      PMCID: PMC476464          DOI: 10.1136/jcp.30.6.537

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Ascites. I. The value of examination of ascitic fluid and blood for lipids and for proteins by electrophoresis.

Authors:  R A ROVELSTAD; L G BARTHOLOMEW; J C CAIN; B F McKENZIE; E H SOULE
Journal:  Gastroenterology       Date:  1958-03       Impact factor: 22.682

2.  Improved methodology and precision using a straight base line technique for the quantitation of proteins by two dimensional immunoelectrophoresis.

Authors:  A R Bradwell; D Burnett
Journal:  Clin Chim Acta       Date:  1975-02-08       Impact factor: 3.786

3.  Carcinoembryonic antigen: synthesis by a continuous line of adenocarcinoma cells.

Authors:  M L Egan; C W Todd
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

4.  Studies on pregnancy-associated globulin.

Authors:  C H Horne; A L McLay; H B Tavadia; I Carmichael; A C Mallinson; A A Laiwah; M A Thomas; R N MacSween
Journal:  Clin Exp Immunol       Date:  1973-04       Impact factor: 4.330

5.  Radioimmune assay of carcinoembryonic antigen.

Authors:  M L Egan; J T Lautenschleger; J E Coligan; C W Todd
Journal:  Immunochemistry       Date:  1972-03

Review 6.  Biochemical monitoring of cancer. A review.

Authors:  A M Neville; E H Cooper
Journal:  Ann Clin Biochem       Date:  1976-01       Impact factor: 2.057

7.  Variations in the level of a pregnancy-associated alpha-macroglobulin in patients with cancer.

Authors:  W H Stimson
Journal:  J Clin Pathol       Date:  1975-11       Impact factor: 3.411

8.  Serum carcinoembryonic antigen in clinical disorders.

Authors:  S N Booth; J P King; J C Leonard; P W Dykes
Journal:  Gut       Date:  1973-10       Impact factor: 23.059

9.  [Demonstration of the carcinoembryonic antigen specific for digestive cancers in human tumors maintained in organotypic culture].

Authors:  P Burtin; D Buffe; S von Kleist; E Wolff; E Wolff
Journal:  Int J Cancer       Date:  1970-01-15       Impact factor: 7.396

10.  Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma.

Authors:  D J Laurence; U Stevens; R Bettelheim; D Darcy; C Leese; C Turberville; P Alexander; E W Johns; A M Neville
Journal:  Br Med J       Date:  1972-09-09
View more
  3 in total

1.  Effect of cigarette smoking, pulmonary inflammation, and lung disease on concentrations of carcinoembryonic antigen in serum and secretions.

Authors:  R A Stockley; J Shaw; A G Whitfield; T P Whitehead; C A Clarke; D Burnett
Journal:  Thorax       Date:  1986-01       Impact factor: 9.139

2.  Tumour associated antigens in diagnosis of serous effusions.

Authors:  J Mezger; W Permanetter; A L Gerbes; W Wilmanns; R Lamerz
Journal:  J Clin Pathol       Date:  1988-06       Impact factor: 3.411

3.  Nonspecific crossreacting antigen (NCA) is a major member of the carcinoembryonic antigen (CEA)-related gene family expressed in lung cancer.

Authors:  T Hasegawa; K Isobe; Y Tsuchiya; S Oikawa; H Nakazato; I Nakashima; K Shimokata
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.